This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Octreotide

Authoring team

Octreotide is a long acting analogue of somatostatin, and is the most effective medical treatment for acromegaly and the carcinoid syndrome.

Actions include:

  • reduces splanchnic arterial flow, portal flow - and results in a reduction in portal hypertension - and gastric mucosal flow; it may be used in the treatment of oesophageal varices, gastointestinal fistulas and complications of pancreatic surgery
  • octreotide has no proven benefit in the treatment of bleeding peptic ulcer
  • may slow the growth of various gastrointestinal malignancies e.g. pancreatic, colorectal and gastric (1)

Reference:

  • BMJ editorial (1994). Somatostatin in gastroenterology. BMJ, 308, 1381-2.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.